- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Weight Management
The Endocrinology Network® Weight Management clinical resource center is the home of all content related to weight loss and obesity management. Now a full-blown epidemic, the obesity crisis is one of the most prominent and dangerous health crises in the US. This page will provide insight and perspective related to FDA approvals, the latest studies, and guideline updates related to nutrition, obesity, and weight management.
Trial Results Suggest Healthy Eating Patterns Could Reduce Cardiovascular Risk in Pediatric Patients
September 22, 2021
A Cleveland Clinic trial assessing the effects of 3 healthy eating patterns in children with overweight or obesity details the improvements in cardiovascular risk factors seen with adherence to a healthy eating pattern.
AHA Outlines Weight Loss Strategies for Preventing Obesity Hypertension
September 20, 2021
Released on September 20, the latest scientific statement from the AHA outlines potential strategies, including lifestyle modifications, pharmacologic therapies, and weight loss surgery, for the prevention and treatment of obesity hypertension.
Young Adults at Greatest Risk of Becoming Overweight, Developing Obesity
September 09, 2021
An analysis of EHR data from more than 2 million patients in England is detailing the increased risk of becoming overweight or developing obesity in the next decade among young adults aged 18-24 compared to adults in other age groups.
Study Draws Link Between Vitamin D Levels and Blood Glucose, BMI and COVID-19 Severity
August 17, 2021
A substudy of a prospective observational study performed at a hospital in Italy details potential associations of vitamin D levels with BMI and blood glucose and severity of COVID-19.
COVID-19, Lockdowns Have Slowed Weight Loss Following Bariatric Surgery
August 12, 2021
An analysis of patients from a hospital in Belgium provides insight into the impact of COVID-19 and lockdowns on weight loss and overall health on patients who underwent gastric bypass and were impacted by COVID-19 during their first postoperative year.
Metabolic Syndrome Raises Secondary Event, Mortality Risk Among Stroke Survivors
August 08, 2021
Patients with metabolic syndrome were at a 46% increased risk of a second stroke and a 27% increased risk of mortality when compared to their counterparts without metabolic syndrome.
Eliminating Just 200 Calories Per Day Could Pay Major Dividends for Heart Health in Obesity
August 03, 2021
An ancillary study to the INFINITE trial details the benefits of caloric restriction plus exercise versus exercise alone on aortic stiffness measured using CMRI in older adults with obesity.
Bariatric Surgery Improves Long-Term Quality of Life, Health Perception in Patients with Uncontrolled T2D
July 27, 2021
An analysis of a subset of patients from the STAMPEDE trial provides new evidence detailing the quality of life improvements associated with undergoing bariatric surgery in patients with uncontrolled type 2 diabetes.
REDUCE-IT BMI: Icosapent Ethyl Provides Consistent Benefit, Regardless of BMI
June 28, 2021
Deepak Bhatt, MD, MPH, discusses the results of REDUCE-IT BMI, which examined effects of icosapent ethyl vs placebo based on baseline BMI, that he presented at ADA 2021.
ADA 2021 Deep Dive into Semaglutide 2.4 mg: A Turning Point for Obesity Management?
June 25, 2021
Ahead of ADA 2021, Dr. Thomas Wadden discusses the significance of the semaglutide 2.4 mg (Wegovy) approval for chronic weight management and Novo Nordisk's plans to evaluate an oral version.